Hospira, Inc., a Pfizer Company: Epinephrine Bitartrate, Lidocaine Hydrochloride Injection shortage update (unavailable from this maker)

Hospira, Inc., a Pfizer Company: Epinephrine Bitartrate, Lidocaine Hydrochloride Injection shortage update (unavailable from this maker). Its amount of 10 is top-decile (95th percentile of 359 records). Dated 17 days ago, it is in the active follow-up window. Score 70/100. As of 2026-11-06, from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).

Data as of · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)

amount: 10 · 95th percentile of 359 DrugShortagePulse records · 3.3x the median

Free preview: all 13 published fields of this record are shown below. Locked: 358 related DrugShortagePulse records and the 5-column CSV export.

FieldValue
ManufacturerHospira, Inc., a Pfizer Company
DrugEpinephrine Bitartrate, Lidocaine Hydrochloride Injection
Dosage formInjection
Therapeutic categoryAnesthesia, Pediatric
StatusCurrent
StageShortage revised (availability or dates changed)
AvailabilityUnavailable
ReasonOther
Presentations affected10
Package NDCs0409-3182-03, 0409-3178-03, 0409-3177-01, 0409-3183-01, 0409-3178-02, 0409-3182-02, 0409-1209-01, 0409-3181-01, 0409-3178-01, 0409-3182-01
Manufacturer supply noteNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
First posted2012-02-22
Updated2026-10-21
amount percentile95th of 359 (median 3, 3.3x median)
Peer records CSV (359 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Hospira, Inc., a Pfizer Company

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Hospira, Inc., a Pfizer + all 359 records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Manufacturer · Drug · Stage · Availability · Updated · official source URL

  • Source agency: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
  • Record date: 2026-10-21
  • Data refreshed: 2026-11-06
  • Refunds on request within 14 days

Search all records free →

Top DrugShortagePulse records: Sanofi-Aventis U.S. LLC · Fresenius Kabi USA, LLC · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Hospira, Inc., a Pfizer Company · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) · Last refreshed: Fri, 06 Nov 2026 09:53:28 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Search, filter and export more DrugShortagePulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

70 / 100 Score

  • Shortage details just changed.
  • Unavailable from this manufacturer.
  • Sterile injectable: hospital and 503B demand.

What is the DrugShortagePulse record for Hospira, Inc., a Pfizer Company?

Hospira, Inc., a Pfizer Company's Epinephrine Bitartrate, Lidocaine Hydrochloride Injection is on the FDA drug shortage list. Shortage revised (availability or dates changed); unavailable from this maker. Last updated 2026-10-21.

How does Hospira, Inc., a Pfizer Company compare to other DrugShortagePulse records?

This is a top-decile record: its amount of 10 is 3.3x the median of 3 across 359 records. It is 17 days old, still within a typical 45-day follow-up window. Its Score of 70/100 puts it among the stronger signals in this feed.

Hospira, Inc., a Pfizer Company vs. top 3 peers

OrganizationAmountPercentileRecord date
Hospira, Inc., a Pfizer Company1095th2026-10-21
Fresenius Kabi USA, LLC791st2026-11-03
Fresenius Kabi USA, LLC577th2026-11-03
Otsuka ICU Medical LLC473rd2026-11-03

Related records

DrugShortagePulse: Shortage revised (availability or dates changed) DrugShortagePulse: Anesthesia

How to monitor Hospira, Inc., a Pfizer Company and peer anesthesia records

Get new DrugShortagePulse records like Hospira, Inc., a Pfizer Company by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new shortages in your categories

DrugShortagePulse emails new and changed FDA drug shortages matching your therapeutic categories.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.

Often used together